UN member states have agreed to hold a Ministerial Segment immediately prior to the 62nd Session of the Commission on Narcotic Drugs (CND) ‘to take stock of the implementation of the commitments made to jointly address and counter the world drug problem, in particular in the light of the 2019 target date’1 set out to eradicate or significantly reduce the overall scale of the illegal drug market. This advocacy note outlines the key issues for consideration by member states as they reflect on what has been achieved since the adoption of the 2009 Political Declaration and Plan of Action, including in light of the implementation of the UNGASS Outcome Document, and the implications for the next phase of the international drug policy regime. In addition, we provide recommendations to address some of the outstanding procedural questions related to the Ministerial Segment in Vienna.
- Period poverty in prisons during the COVID-19 pandemic: Submission to the UN Special Rapporteur on health
- Synthetic Drugs in East and Southeast Asia: latest developments and challenges 2021
- Turning off the tap: The state of HIV prevention funding in Southern Africa
- European Drug Report 2021
- Quality standards of civil society involvement in drug policies
- Survey of client satisfaction with opioid substitution program in western Georgia
- 1st Brandenburg Forum (BBF) in Geneva "Building bridges between the drug policy and human rights regimes of the United Nations"
- Arbitrary detention relating to drug policies - Study of the UN Working Group on Arbitrary Detention
- Global law & policy progress on human rights, equality, stigma and discrimination